Neoplasia Oncogene vs Tumor Suppressor

0.0(0)
Studied by 12 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/17

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 5:30 PM on 8/10/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

18 Terms

1
New cards

Describe Oncogenes

  • Definition?

  • Which type of genes affected?

  • Common Genes affected?

Oncogenes:

  • Definition:

    • Mutated genes -> excessive growth/over expression 

      • Gain of Function Mutation in only one allele

  • Occurs in genes:

    • Signal transduction proteins

    • Growth factor receptors

    • Growth factors

    • Nuclear regulatory proteins

    • Cell cycle regulators – cyclins

  • Common genes affected 

    • KRAS, 

    • BRAF,

    • EGFR,

    • MYC

2
New cards
  1. Draw out the Growth factor Receptor Pathway

    1. What is the type of mutation in signal transduction proteins that causes uncontrolled growth?

Point Mutations

<p>Point Mutations</p>
3
New cards

Describe the RAS gene (KRAS)

  • What are they?

    • Types?

  • STATS

  • How does KRAS mutation → oncogene

  • What are they?

    • Signal Transducers genes

      • KRAS, NRAS, HRAS

        • KRAS = most common

  • STATs

    • 15-20% of all human tumors have RAS mutations

    • Found in:

      • 90% of pancreatic adenocarcinoma

      • 50% of colon, endometrial and thyroid cancers

      • 30% of lung adenocarcinomas

  • How does KRAS mutation -> Oncogene:

    • KRAS (inactive) -> KRAS (active) via GDP -> GTP

      • Active -> inactive via GTPase activity (backwards)

    • Mutation -> reduce GTPase activity

    • Continuous active RAS = continuous growth signal

NOTE: When RAS gene mutations are present in a tumor, growth receptor mutations are usually absent

4
New cards

Describe the BRAF gene

  • What is it?

  • Clinical Importance

BRAF gene

  • What is it?

    • member of serine/threonine protein kinase family

  • Clinical Importance:

    • Mutation (V600E) -> 100% of hairy cell leukemia and 60% of melanoma

5
New cards

Describe Growth Factor Receptors

  • Encoded by?

  • Mech

  • Mutations?

  • Notable Receptor Names?

  • List some growth receptor mutations and associated cancers

Growth factor receptors

  • Encoded by?

    • Oncogenes

  • Mech:

    • Tyrosine kinase receptors tranduces growth signal across cell membrane

  • Mutations

    • point mutations, amplifications and translocations

  • Notable Receptor Names

    • EGFR, HER2 and ALK 

  • Growth Receptor mutation and associated cancers

    • EGFR point mutation -> lung adenocarcinomas

    • HER2 amplification -> Breast Carcinoma

    • ALK translocation to EML4 -> fusion protein EML4-ALK -> lung adenocarcinoma

6
New cards

What do Glioblastomas  express that correlates to its own growth?

Expresses PDGF (platelet derived growth factor) + own receptor -> own growth

7
New cards

Describe MYC

  • Function/Mech

  • Related Cancers/Mutations

MYC 

  • Function/Mech:

    • Promotes Cell Division

      • Induces trxn of:

        • Cyclin D2, Cyclin E, + various CDKs

      • Removes Cell Cycle Brakes

  • Related Cancers/Mutations

    • Burkitt lymphoma (Translocation)

    • Neuroblastoma (amplification)

8
New cards

Describe Cyclins and CDK (Cyclin dependent kinases) 

  • Function? Chekcpoints?

  • Related Cancers/Mutations

Cyclins and CDK (Cyclin dependent kinases) 

Function:

  • Regulates progression through cell cycle

  • Two main checkpoints: G1/S and G2/M

Related Cancers/Mutations

  • D- Cyclin: Gain of function mutation -> unregulated growth/function as oncogenes

  • Lymphoma: translocations of Cyclin D1

9
New cards

Draw out how cyclin/CDKs progress the cell cycle

knowt flashcard image
10
New cards

Describe Tumor Suppressor Gene

  • Function

  • Notable Genes

  • Mutation

  • What do these genes control?

  • Common genes affected → cancer?

Tumor Suppressor Gene

  • Function:

    • recognize DNA abnormality -> cell growth inhibition

      •  Cell cycle arrest or apoptosis

  • Notable Genes:

    • Retinoblastoma (RB)

    • Tumor Protein 53 (p53)

  • Mutation:

    • Loss of Function

  • Occur In genes that control:

    • Cell cycle progression

    • Mitosis signaling pathway

    • DNA repair

      • EX: BRCA: breast cancer

      • EX: DNA mismatch repair: Colon Cancer

  • Common genes affected:

    • APC, VHL

11
New cards

Describe Retinoblastoma

  • What is it

  • Genetics?

  • Knudson two-hit hypothesis?

  • Function? Mech?

  • How can Retinoblastoma lose function?

Retinoblastoma

  • What is it?

    • Primary intraocular malignancy in children

  • Genetics:

    • 40% inherited (germline), 60% sporadic

    • Autosomal dominant

    • Mutation in retinoblastoma gene

      • Increases risk of dev. Retinoblastoma 10,000x

  • Knudson two-hit hypothesis

    • Two mutations are req. for dev. of retinoblastoma (one on each allele)


Retinoblastoma function

  • Inhibits G1/S transition 

  • Stops cell cycle in non-phosphorylated state 

Mech:

  • In non-phosphorylated state -> stops cell cycle

    • By blocking trxn of S phase genes


How can Retinoblastoma lose function

  • Mutations in both RB genes

  • CDK4 + cyclin D genes amplification

  • cyclin dependent kinases inhibitors ((p16/INK4a)) Loss of Function

  • Virus that inhibits RB (HPV)

12
New cards

Describe p53

  • Nickname?

  • Clinical Importance

  • Function

  • Mech.

  • P53 loss of function consequences:

  • What is Li-Fraumeni syndrome

Tumor protein 53 (p53)

  • Nickname?

    • Nicknamed “Guardian of Genome” b/c trxn. regulator

  • Clinical Importance:

    • Loss of function mutation -> detected in 50% of cancers

  • Function:

    • Controls cell cycle arrest and DNA repair

  • Mechanism:

    • DNA damage, hypoxia, cell stress -> detected by ATM/ATR proteins -> release p53 from MDM2 -> accumulation

      • If DNA can’t repair -> p53 induces apoptosis/cease mitosis

  • P53 loss of function consequences:

    • accumulation of mutations

    • continued cell proliferation 

    • increased risk of malignant transformation

    • Cancers w/ p53 mutations -> resistant to chemo + radiation therapy

      • Lung/colon

  • Li-Fraumeni syndrome

    • P53 inherited mutations -> 25x risk of developing Cancers (wide range)

13
New cards

Draw out the p53 pathway

knowt flashcard image
14
New cards

Differentiate between Syndromic and Sporadic mutations

Syndromic: Germline mutations inherited

Sporadic: Somatic Mutations Acquired

15
New cards

Describe the PTEN gene (Phosphatase and tensin homolog)

  • Function

  • Describe Cowden Syndrome

    • Gene?

    • Consequence?

  • Function:

    • Negative regulator of PI3K/AKT signaling

  • Cowden Syndrome

    • Gene: Autosomal dominant

    • Consequence:

      • Benign growths of skin

        • (lipoma, fibromas)

      • Increased risk of breast/endometrial carcinoma

16
New cards

Describe the APC gene (Adenomatous polyposis coli)

  • Function?

  • Describe Adenomatous polyposis coli

    • Gene?

    • Consequence?

    • Stats?

APC gene (Adenomatous polyposis coli)

  • Function:

    • Tumor Suppressor gene -> inhibits mitosis signaling pathway

  • Adenomatous polyposis coli

    • GENE: Autosomal dominant

    • Consequence:

      • 1 mutant allele -> 1000s of adenomas

      • 2 mutant allele -> colon cancer

    • Stats

      • 70-80% of sporadic colon cancer have mutations in APC (somatic mutations)

17
New cards
term image
knowt flashcard image
18
New cards

Describe the VHL gene

  • Function

  • Describe Von Hippel-Lindau syndrome

    • Gene

    • Consequences

  • Function:

    • Regulates cellular response to O2 levels

  • Von Hippel-Lindau syndrome

    • GENE: Autosomal dominant

    • Consequence:

      • renal cell carcinoma Risk

      • Clear cell type Risk

      • Pheochromocytoma Risk

      • Sporadic Renal Cell cancer

        • Has VHL mutations